🔎 Trials Near Me

Home › Flu › Arizona

Flu clinical trials in Arizona

6 studies for Flu are looking for participants at sites in Arizona.

Cities in Arizona

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

  • Hope Research Institute ( Site 0575), Glendale
  • Hope Research Institute ( Site 0587), Tempe
  • Del Sol Research Management, LLC ( Site 0515), Tucson
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 13, 2026 · NCT07159763

A Study of Updated mRNA Seasonal Influenza Vaccines

  • Arizona Clinical Trials, Tucson
RecruitingPhase 4Healthy volunteers welcome
Ages 65 and older · All sexes · Updated Nov 13, 2026 · NCT07884175

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05624450

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

  • GSK Investigational Site, Glendale
  • GSK Investigational Site, Tucson
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 64 · All sexes · Updated Oct 9, 2026 · NCT07851246

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

  • GSK Investigational Site, Glendale
  • GSK Investigational Site, Mesa
  • GSK Investigational Site, Mesa
  • and 9 more
RecruitingPhase 3Healthy volunteers welcome
Ages 65 and older · All sexes · Updated Sep 18, 2026 · NCT07805707

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

  • AMR Clinical Phoenix, Arizona- Site Number : 8400004, Tempe
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07779408

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.